Abstract
Background: Hydrogen sulfide (H2S) is a naturally occurring gaseous transmitter, which may play important roles in normal physiology and disease. Here, we investigated the effect of endogenously formed H2S in the endotoxemic organ injury.
Methods: Male Wistar rats were subjected to acute endotoxemia [Escherichia coli lipopolysaccharide (LPS) 20 mg kg−1, intraperitoneally (ip)]. A group of animals was injected d,l-propargylglycine (PAG, 50 mg kg−1,ip), an inhibitor of the H2S-synthesizing enzyme cystathionine-γ-lyase (CSE), 60 min before LPS administration. Six hours after the LPS treatment, animals were sacrificed. Myeloperoxidase (MPO), dimethylarginine dimethylaminohydrolase (DDAH) activities and levels of nitrotyrosine and GSH were measured in the liver. Asymmetric dimethylarginine (ADMA) and arginine levels in both liver and plasma were determined using HPLC.
Results: LPS injections caused liver injury, as evidenced by the activities of serum aspartate aminotransferase and arginase. After LPS injections, increased arginine content and arginine/ADMA ratio were observed in the liver, together with significant decrements in both DDAH activity and GSH levels. Despite the accumulation of ADMA in the plasma, its level remained unchanged in the liver. PAG pretreatment aggravated the LPS-induced increase in the activities of MPO and serum enzymes. The most profound effect of PAG pretreatment was observed in nitrotyrosine levels in the liver, which were increased significantly as compared with the control and LPS-injected groups.
Conclusion: These findings support the view that the suppression of nitrosative stress by endogenous H2S is one of the mechanisms to protect liver against endotoxemic injury.
Similar content being viewed by others
References
Łowicka E, Bełtowski J. Hydrogen sulfide (H2S) – the third gas of interest for pharmacologists. Pharmacol Rep 2007;59:4–24.
Wagner F, Asfar P, Calzia E, Radermacher P, Szabó C. Bench-to-bedside review: hydrogen sulfide—the third gaseous transmitter: applications for critical care. Crit Care 2009;13:213.
Whiteman M, Winyard PG. Hydrogen sulfide and inflammation: the good, the bad, the ugly and the promising. Expert Rev Clin Pharmacol 2011;4:13–32.
Chai W, Wang Y, Lin JY, Sun XD, Yao LN, Yang YH, et al. Exogenous hydrogen sulfide protects against traumatic hemorrhagic shock via attenuation of oxidative stress. Surg Res 2012;176:210–9.
Bracht H, Scheuerle A, Grö ger M, Hauser B, Matallo J, McCook O, et al. Effects of intravenous sulfide during resuscitated porcine hemorrhagic shock. Crit Care Med 2012;40:2157–67.
Dudek M, Bilska-Wilkosz A, Knutelska J, Mogilski S, Bednarski M, Zygmunt M, et al. Are anti-inflammatory properties of lipoic acid associated with the formation of hydrogen sulfide? Pharmacol Rep 2013;65:1018–24.
Ang SF, Moochhala SM, MacAry PA, Bhatia M. Hydrogen sulfide and neurogenic inflammation in polymicrobial sepsis: involvement of substance P and ERK-NF-ĸB signaling. PLoS ONE 2011;6:e24535.
Yan Y, Chen C, Zhou H, Gao H, Chen L, Chen L, et al. Endogenous hydrogen sulfide formation mediates the liver damage in endotoxemic rats. Res Vet Sci 2013;94:590–5.
Mok YY, Moore PK. Hydrogen sulphide is pro-inflammatory in haemorrhagic shock. Inflamm Res 2008;57:512–8.
Mayer B, Hemmens B. Biosynthesis and action of nitric oxide in mammalian cells. Trends Biochem Sci 1997;22:477–81.
Rawlingson A. Nitric oxide, inflammation and acute burn injury. Burns 2003;29:631–40.
Mashimo H, Goyal RK. Lessons from genetically engineered animal models. IV: Nitric oxide synthase gene knockout mice. Am J Physiol 1999;277:G745–50.
Hierholzer C, Billiar TR. Molecular mechanisms in the early phase of hemorrhagic shock. Langenbecks Arch Surg 2001;386:302–8.
Mori M, Gotoh T. Regulation of nitric oxide production by arginine metabolic enzymes. Biochem Biophys Res Commun 2000;275:715–9.
Mosser DM. The many faces of macrophage activation. J Leukoc Biol 2003;73:209–12.
Corraliza IM, Campo ML, Soler G, Modolell M. Determination of arginase activity in macrophages: a micromethod. J Immunol Methods 1994;174:231–5.
MacAllister RJ, Parry H, Kimoto M, Ogawa T, Russell RJ, Hodson H, et al. Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase. Br J Pharmacol 1996;119:1533–40.
Leiper J, Murray-Rust J, McDonald N, Vallance P. S-nitrosylation of dimethylarginine dimethylaminohydrolase regulates enzyme activity: further interactions between nitric oxide synthase and dimethylarginine dimethylaminohydrolase. Proc Natl Acad Sci U S A 2002;99:13527–32.
Beutler E, Duron O, Kelly BM. Improved method for the determination of blood glutathione. J Lab Clin Med 1963;61:882–8.
Rachmilewitz D, Stamler JS, Karmeli F, Mullins ME, Singel DJ, Loscalzo J, et al. Peroxynitrite-induced rat colitis—a new model of colonic inflammation. Gastroenterology 1993;105:1681–8.
Teerlink T. Determination of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine in biological samples by HPLC. Methods Mol Med 2005;108:263–74.
Tain YL, Baylis C. Determination of dimethylarginine dimethylaminohydrolase activity in the kidney. Kidney Int 2007;72:886–9.
Bronte V, Zanovello P. Regulation of immune responses by L-arginine metabolism. Nat Rev Immunol 2005;5:641–54.
Venketaraman V, Talaue MT, Dayaram YK, Peteroy-Kelly MA, Bu W, Connell ND. Nitric oxide regulation of L-arginine uptake in murine and human macrophages. Tuberculosis (Edinb) 2003;83:311–8.
Szabó C, Mó dis K. Pathophysiological roles of peroxynitrite in circulatory shock. Shock 2010;4–14.
Hausladen A, Fridovich I. Superoxide and peroxynitrite inactivate aconitases, but nitric oxide does not. J Biol Chem 1994;269:29405–08.
Brunelli L, Crow JP, Beckman JS. The comparative toxicity of nitric oxide and peroxynitrite toEscherichia coli. Arch Biochem Biophys 1995;316:327–34.
Szabó C, Salzman AL. Endogenous peroxynitrite is involved in the inhibition of mitochondrial respiration in immuno-stimulated J774.2 macrophages. Biochem Biophys Res Commun 1995;209:739–43.
Virág L, Szabó E, Gergely P, Szabó C. Peroxynitrite-induced cytotoxicity: mechanism and opportunities for intervention. Toxicol Lett 2003;140-141:113–24.
Szabó C. Mechanisms of cell necrosis. Crit Care Med 2005;33:S530–4.
Halliwell B. What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo? FEBS Lett 1997;411:157–60.
Tan G, Pan S, Li J, Dong X, Kang K, Zhao M, et al. Hydrogen sulfide attenuates carbon tetrachloride-induced hepatotoxicity, liver cirrhosis and portal hypertension in rats. PLoS ONE 2011;6:e25943.
Wang K, Ahmad S, Cai M, Rennie J, Fujisawa T, Crispi F, et al. Dysregulation of hydrogen sulfide producing enzyme cystathionine-γ-lyase contributes to maternal hypertension and placental abnormalities in preeclampsia. Circulation 2013;127:2514–22.
Norris EJ, Feilen N, Nguyen NH, Culberson CR, Shin MC, Fish M, et al. Hydrogen sulfide modulates sinusoidal constriction and contributes to hepatic microcirculatory dysfunction during endotoxemia. Am J Physiol Gastrointest Liver Physiol 2013;304:G1070–78.
Hua W, Zhou SL, Gong FQ. Biphasic regulation of hydrogen sulfide in inflammation. Chin Med J (Engl) 2013;126:1360–3.
Wallace JL. Hydrogen sulfide-releasing anti-inflammatory drugs. Trends Pharmacol Sci 2007;28:501–5.
Whiteman M, Armstrong JS, Chu SH, Jia-Ling S, Wong BS, Cheung NS, et al. The novel neuromodulator hydrogen sulfide: an endogenous peroxynitrite ‘scavenger’. J Neurochem 2004;90:765–8.
Whiteman M, Li L, Kostetski I, Chu SH, Siau JL, Bhatia M, et al. Evidence for the formation of a novel nitrosothiol from the gaseous mediators, nitric oxide and hydrogen sulphide. Biochem Biophys Res Commun 2006;343:303–10.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bekpinar, S., Unlucerci, Y., Uysal, M. et al. Propargylglycine aggravates liver damage in LPS-treated rats: Possible relation of nitrosative stress with the inhibition of H2S formation. Pharmacol. Rep 66, 897–901 (2014). https://doi.org/10.1016/j.pharep.2014.05.014
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1016/j.pharep.2014.05.014